Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Catalent
Pharma
FTC to review Novo Holdings' Catalent buyout for 30 more days
After Novo Holdings pitched a $16.5 billion buyout of Catalent in February, the companies have given the FTC extra time to review the deal.
Fraiser Kansteiner
Apr 8, 2024 11:58am
Catalent conducting fresh round of layoffs in Indiana
Mar 21, 2024 12:27pm
Catalent reorg leaves 300 without jobs as CDMO awaits buyout
Feb 15, 2024 8:45am
Catalent's sales continue to be plagued by low COVID demand
Feb 9, 2024 9:55am
Catalent's Indiana filling plant in hot water with the FDA again
Feb 7, 2024 2:11pm
Amid GLP-1 supply constraints, Lilly to prep for orals 'at risk'
Feb 6, 2024 2:36pm